PARP Inhibitors in Metastatic Prostate Cancer: Evidence to Date

Poly (ADP-ribose) polymerase inhibitors (PARPi) are a unique class of antineoplastic agents that function by inducing synthetic lethality. Synthetic lethality occurs when PARPi and either another agent or an underlying genetic alteration together lead to overwhelming DNA damage and ultimately cell d...

Descripción completa

Detalles Bibliográficos
Autores principales: Nizialek, Emily, Antonarakis, Emmanuel S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489946/
https://www.ncbi.nlm.nih.gov/pubmed/32982407
http://dx.doi.org/10.2147/CMAR.S227033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489946/
https://www.ncbi.nlm.nih.gov/pubmed/32982407
http://dx.doi.org/10.2147/CMAR.S227033

Ejemplares similares